Diamyd: Completed Phase II enrollment

Diamyd completed enrollment of 50 children aged >=4 years with a high risk of developing Type I diabetes in the double-blind, placebo-controlled, Swedish Phase II DiAPREV-IT trial evaluating 20 µg Dia...